Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


Articles published in J Nucl Med

Retrieve available abstracts of 5 articles:
HTML format
Text format



Single Articles


    June 2018
  1. WOFF E, Hendlisz A, Ameye L, Garcia C, et al
    Metabolic Active Tumor Volume and Total Lesion Glycolysis by (18)F-FDG PET/CT Validated as Prognostic Imaging Biomarkers in Chemorefractory Metastatic Colorectal Cancer.
    J Nucl Med. 2018 Jun 29. pii: jnumed.118.210161. doi: 10.2967/jnumed.118.210161.
    PubMed     Text format     Abstract available


    February 2018
  2. SCHELHAAS S, Wachsmuth L, Hermann S, Rieder N, et al
    Thymidine Metabolism as Confounding Factor of 3'-Deoxy-3'-[(18)F]Fluorothymidine Uptake after Therapy in a Colorectal Cancer Model.
    J Nucl Med. 2018 Feb 23. pii: jnumed.117.206250. doi: 10.2967/jnumed.117.206250.
    PubMed     Text format     Abstract available


    October 2017
  3. GRKOVSKI M, Emmas SA, Carlin SD
    18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy.
    J Nucl Med. 2017;58:1567-1573.
    PubMed     Text format     Abstract available


    September 2017
  4. BOAS FE, Bodei L, Sofocleous CT
    Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes.
    J Nucl Med. 2017;58.
    PubMed     Text format     Abstract available


    March 2017
  5. HOUARD C, Pinaquy JB, Henriques DE Figueiredo B, Mesguich C, et al
    Role of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in post-treatment evaluation of anal carcinoma.
    J Nucl Med. 2017 Mar 9. pii: jnumed.116.185280. doi: 10.2967/jnumed.116.185280.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: